Unicycive Therapeutics, Inc. (UNCY)

Key Insights

• Gaurav Aggarwal, a director of Unicycive Therapeutics, has resigned from the Board of Directors, but his resignation was not due to any disagreement with the company.
• The company has expressed gratitude to Dr. Aggarwal for his service on the Unicycive Board of Directors.
• This leadership change may signal a transition or shift in the company's strategic direction, which investors should monitor.